Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction
- PMID: 22879076
- DOI: 10.1007/s12350-012-9609-7
Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction
Abstract
Background: Cardiovascular risk factors are classically associated with coronary atherosclerosis. We sought to investigate whether risk factors are also associated with left ventricular (LV) dilatation, contractile impairment and reduced myocardial blood flow (MBF) in patients with non-ischemic LV dysfunction.
Methods: We studied 81 patients (59 males, age 60 ± 9 years) with mild-to-severe LV dysfunction (mean ejection fraction 37%, range 19%-50%), no history of diabetes and normal coronary arteries. Absolute MBF was measured by positron emission tomography and (13)N-ammonia at rest and after dipyridamole (0.56 mg/kg I.V. over 4 min).
Results: Overt LV dysfunction (LV end-diastolic diameter >60 mm associated with LV ejection fraction <45%) was present in 42 patients (52%); severely depressed hyperemic MBF (<1.09 mL · min(-1) · g(-1)) was present in 41 patients (51%). Using multivariate logistic regression analysis, low high-density lipoprotein cholesterol (HDL-C, P < .036), newly diagnosed non-insulin-dependent diabetes or insulin-resistance (NIDD/IR, P < .019) and the use of diuretics (P = .001) were independently associated with overt LV dysfunction. Low HDL-C (P = .015) and NIDD/IR (P = .048) were also independently associated with severely depressed hyperemic MBF.
Conclusions: Low HDL-C and NIDD/IR are associated with more severe LV impairment and reduced hyperemic MBF in non-ischemic LV dysfunction.
Similar articles
-
Simultaneous assessment of coronary flow reserve and left ventricular function during vasodilator stress evaluated by 13N-ammonia hybrid PET/MRI.Clin Radiol. 2021 Jun;76(6):472.e1-472.e9. doi: 10.1016/j.crad.2021.02.019. Epub 2021 Mar 19. Clin Radiol. 2021. PMID: 33752883
-
Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction.Circulation. 2002 Jan 15;105(2):186-93. doi: 10.1161/hc0202.102119. Circulation. 2002. PMID: 11790699
-
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.Circulation. 1995 Aug 15;92(4):796-804. doi: 10.1161/01.cir.92.4.796. Circulation. 1995. PMID: 7641359
-
Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.Metabolism. 2011 Feb;60(2):227-33. doi: 10.1016/j.metabol.2009.12.030. Epub 2010 Mar 4. Metabolism. 2011. PMID: 20199784 Free PMC article.
-
Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.J Am Coll Cardiol. 2006 Mar 7;47(5):1043-8. doi: 10.1016/j.jacc.2005.10.050. J Am Coll Cardiol. 2006. PMID: 16516091
Cited by
-
Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD.J Clin Endocrinol Metab. 2016 Jul;101(7):2701-10. doi: 10.1210/jc.2015-4091. Epub 2016 Apr 5. J Clin Endocrinol Metab. 2016. PMID: 27045985 Free PMC article.
-
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.J Atheroscler Thromb. 2017 Aug 1;24(8):853-862. doi: 10.5551/jat.37101. Epub 2016 Dec 15. J Atheroscler Thromb. 2017. PMID: 27980243 Free PMC article.
-
Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients.Eur J Nucl Med Mol Imaging. 2013 Sep 11. doi: 10.1007/s00259-013-2523-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2013. PMID: 24022659
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous